Viscosupplementation Market Is Likely to Grasp the CAGR of 8.5 by 2029, Size, Share, Demand, Growth Drivers, Trends, Segmentation and Competitive Outlook

VANCOUVER, BC, Nov. 29, 2022 /PRNewswire/ -- Data Bridge Market Research has recently published a Report, titled, "Viscosupplementation Market" The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter's Five Forces analysis, and competitive landscape. To accomplish maximum return on investment (ROI), it's very essential to be acquainted with market parameters such as brand awareness, market landscape, possible future issues, industry trends and customer behaviour where this Viscosupplementation report comes into play. With this market report, information about all the above mentioned factors can be retrieved by using actionable market insights and comprehensive market analysis. The key topics that have been explained in this market report include market definition, market segmentation, key developments, competitive analysis and research methodology. Not to mention these topics have been watchfully analysed with the best tools and techniques.

Global viscosupplementation market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 8.5% in the forecast period of 2022 to 2029. Technological advancements in viscosupplementation treatments rise in the healthcare sector are another factor that drives the growth of the global viscosupplementation market in the forecast period.

Download Sample Copy of Viscosupplementation Market @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-viscosupplementation-market

Market Overview:

The development of the therapeutic paradigm viscosupplementation for long-lasting pain relief in human and animal joints with osteoarthritis or traumatic arthritis was based on the finding that in arthritic conditions, the average molecular weight and concentration of hyaluronan decreased. Consequently, the elastoviscous properties of the synovial fluid are substantially reduced. Viscosupplementation is a therapeutic process in which the pathological synovial fluid or effusion is removed from the joint by arthrocentesis and is replaced with a highly purified hyaluronan solution which has a 16- to 30-times greater concentration than the pathological joint fluid, and a 2- to 5-times greater concentration than that of the hyaluronan in the healthy synovial fluid. In some preparations of hyaluronan used today for therapeutic purposes, the rheological properties (viscosity and elasticity) are low

However, the high cost associated with the treatments and side effects such as temporary injection, site pain, swelling, heat, and redness loss will restrain the market's growth. Adoption of strategic alliances like partnerships and acquisitions by key market players act as an opportunity for the growth of the global viscosupplementation market.

Furthermore, the increasing demand for non-surgical treatments for osteoarthritis, the prevalence of lifestyle-induced disorders, and advancements in the development of hyaluronic acid-based therapies are some of the factors expected to drive the market.

Opportunities for Players:

• Safety and effectiveness of intra-articular hyaluronic acid (IAHA)

There are several types of hyaluronic acid injections, also called viscosupplementation, which are used for knee osteoarthritis. They are made from either rooster or chicken combs or are derived from bacteria and are injected directly into the joint. Intra-articular hyaluronic acid is a US Food and Drug Administration-approved treatment for knee osteoarthritis (OA). Intra-articular hyaluronic acid (IAHA) injection presents an alternative local treatment option providing symptomatic benefit without the systemic AEs associated with IA corticosteroids. Numerous RCTs and meta-analyses have sought to assess the efficacy and safety of IAHA, with mixed results and conclusions. IAHA is demonstrated to have a positive effect on pain and joint function. There is also mounting data showing that multiple courses of IAHA can impact long-term outcomes, including a reduction in concomitant analgesia use and a delay in the need for total knee replacement surgery.

Some of the major players operating in the Viscosupplementation market are:

• Anika Therapeutics, Inc.,
• SEIKAGAKU CORPORATION,
• Bioventus,
• Fidia Farmaceutici S.P.A,
• Ferring B.V,
• sanofi-aventis U.S. LLC,
• Zimmer Biomet,
• OrthogenRx, Inc. (a subsidiary of AVNS),
• APTISSEN,
• Johnson & Johnson Services, Inc.,
• LG Chem.,
• Viatris Inc.,
• IBSA Institut Biochimique SA,
• Ortobrand International,
• TRB CHEMEDICA SA,
• Teva Pharmaceutical Industries Ltd.,
• Lifecore (a subsidiary of Landec Corporation),
• VIRCHOW BIOTECH,
• Zuventus HealthCare

Get Full PDF Research Report to Understand More @ https://www.databridgemarketresearch.com/checkout/buy/enterprise/global-viscosupplementation-market

Recent Industry Developments:

• In June 2022, Johnson & Johnson announced new data from Phase 3 studies demonstrating patients treated with medicine achieved consistent, long-term efficacy through two years across the domains of active psoriatic arthritis (PsA) – including joint, skin, enthesitis, a dactylitis,b spinal pain, and disease severityc endpoints – irrespective of baseline characteristics. This has helped company to showcase its progress
• In November 2020, Viatris Inc. launched a successful combination of Mylan N.V. and Pfizer's Upjohn business. By combining these two complementary legacy companies, Viatris has the scientific, manufacturing, and distribution expertise with proven regulatory, medical and global commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories. This has helped company to expand its business

The report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios of the top players in the Viscosupplementation market

Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the market

Competitive Assessment: In-depth assessment of the market strategies, and geographic and business segments of the leading players in the market

Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies

Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Viscosupplementation Market

THANKSGIVING WEEK SALE!!!

Get UP TO 35%. OFF ON GLOBAL REPORTS. OFFER VALID TILL 30th NOV 2022

For More, Inquire at https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-viscosupplementation-market

Critical Insights Related to the Viscosupplementation Included in the Report:

• Exclusive graphics and Illustrative SWOT analysis of some of the leading companies in this market
• Value chain analysis of prominent players in the market
• Current trends influencing the dynamics of this market across various geographies
• Recent mergers, acquisitions, collaborations, and partnerships
• Revenue growth of this industry over the forecast period
• Marketing strategy study and growth trends
• Growth driven factor analysis
• Emerging recess segments and region-wise market
• An empirical evaluation of the curve of this market
• Ancient, Present, and Probable scope of the market from both prospect value and volume

Market Dynamics: Viscosupplementation Market

• Rising geriatric population

With this increasing age comes a reciprocal increase in the elderly patients admitted to the hospitals due to fatal traumatic injuries. The rising prevalence of knee osteoarthritis diseases leads to increasing demand for diagnosis and treatment. With the growing population, the pressure on the healthcare system is rising. The increasing need for the proper treatment proportionally surges the demand for care, services, and technologies for the prevention and treatment of knee osteoarthritis conditions such as sarcopenia, osteoporosis, osteopenia, and other complications. The elderly population is more prone to these conditions leading to fragile bones and joints. In such patients, viscosupplementation is used in the procedure to provide them with immediate and efficient benefits associated with their bodies.

With this increasing age and rising prevalence of osteoarthritis, the demand for early diagnosis of the diseases is also increasing. Therefore, the demand for viscosupplementation is rising for the treatment in the healthcare system across the globe.

• Increasing risk of osteoporosis and osteoarthritis

Osteoporosis is a disease of bone that progresses due to less bone mineral density and bone mass or due to some variation in the quality or structure of bone. Osteoporosis could increase the risk of fractures leading to broken bones due to decreased bone strength. It is more observed in women as compared to men. The post-menstrual women often get bone fractures due to osteoporosis as the disease is silent and typically shows no symptoms. Mostly elderly people are more prone to osteoporosis. Osteoarthritis is a joint disease or an inflammation of the joints and surrounding tissues. The mobility of a person is affected when such conditions occur.

The silent diseases such as osteoporosis and osteoarthritis show no symptoms and weaken the person's bone, leading to major fatalities such as spine malformation, fracture, sudden fall, or breakage of bone, among others. Thus, the increased risks of these conditions directly enhance the demand for viscosupplementation required to treat the malformations due to such conditions. Therefore, the increasing risk of osteoporosis and osteoarthritis is anticipated to drive the growth of viscosupplementation market

Challenges:

• Lack of technical expertise

Finding, attracting, and hiring talent is also the first step in building a professional bench of engineers and technicians. Even in the best of circumstances, this procedure can be challenging. Manufacturing existing workforce is rapidly aging and retiring. In the medical industry, there is a scarcity of STEM (science, technology, engineering, and mathematics) skills. Although demand for skilled tradespeople (technicians) and undergraduate/post-graduate skills (engineers) remains strong in manufacturing, the number of people with the necessary skills is approaching a trickle. Only trained professionals should perform viscosupplementation, but this number is much less across the globe as these procedures are complex.

However, putting together a good additive manufacturing (AM) workforce entails more than just finding and recruiting qualified candidates. Employees must be qualified to remain current and maintain required skills as technology shift and grow. Even with their STEM-focused education, newly minted engineers would certainly need on-the-job training in AM techniques, which is one of the major challenges of recruiting and hiring them. Indeed, many undergraduate engineering programs provide little in the way of AM-specific education, and as a result, many graduates can lack the AM skills that employers seek.

To Gain More Insights about this Research, Visit @ https://www.databridgemarketresearch.com/reports/global-viscosupplementation-market

Key Industry Segmentation: Viscosupplementation Market

By Source

• Animal Origin
• Non-Animal Origin

By Molecular Weight

• High Molecular Weight
• Low Molecular Weight
• Intermediate Molecular Weight

By Injection

• Single Injection
• Three Injection
• Five Injection

By Age Group

• Adults
• Geriatrics

End-User

• Hospitals
• Orthopedic Clinic
• Home Healthcare

By Distribution Channel

• Direct Tender
• Retail Sales

Regional Analysis/Insights: Viscosupplementation Market

The countries covered in the viscosupplementation market report are the U.S., Canada, Mexico, Panama, Jamaica, and the Dominican Republic, Germany, France, U.K., Italy, Spain, Russia, Turkey, Netherlands, Switzerland, Poland, Austria, Hungary, Lithuania, Norway, Ireland, and the rest of Europe, China, Japan, India, South Korea, Singapore, Australia, Thailand, Vietnam, Malaysia, Taiwan, Indonesia, Philippines, and Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, South Africa, Kuwait, and rest of the Middle East and Africa, Brazil, Argentina, Peru, Colombia, Chile, Ecuador, Uruguay, Venezuela, Bolivia, Paraguay, Trinidad and Tobago, Curaçao, and the rest of South America.

In 2022, North America is dominating due to the presence of key market players in the largest consumer market with high GDP. The U.S is expected to grow due to the rise in technological advancement in drug treatments.

Table of Contents:

1.  Introduction

2.  Market Segmentation

3.  Executive Summary

4.  Premium Insights

5.  Global Viscosupplementation Market: Regulations

6.  Market Overview

7.  Global Viscosupplementation Market, By Source

8.  Global Viscosupplementation Market, By Molecular Weight

9.  Global Viscosupplementation Market, By Injection

10.  Global Viscosupplementation Market, By Age Group

11.  Global Viscosupplementation Market, By End User

12.  Global Viscosupplementation Market, By Distribution Channel

13.  Global Viscosupplementation Market, By Region

14.  Global Viscosupplementation Market: Company Landscape

15.  SWOT Analyses

16.  Company Profile

17.  Questionnaires

18.  Related Reports

To Check the Complete Table of contents, click here @ https://www.databridgemarketresearch.com/toc/?dbmr=global-viscosupplementation-market

Explore More Reports:

Asia-Pacific viscosupplementation Market, By Source (Animal Origin And Non-Animal Origin), Age Group (Geriatric And Adults), Injection (Single Injection, Three Injections, And Five Injections), Molecular Weight (Intermediate Molecular Weight, Low Molecular Weight And High Molecular Weight), End User (Hospital, Orthopedic Clinics, Ambulatory Care Centers, And Others), Distribution Channel (Direct Tender And Retail Sales) https://www.databridgemarketresearch.com/reports/asia-pacific-viscosupplementation-market

North America Viscosupplementation Market, By Source (Animal Origin And Non-Animal Origin), Age Group (Geriatric And Adults), Injection (Single Injection, Three Injections, And Five Injections), Molecular Weight (Intermediate Molecular Weight, Low Molecular Weight And High Molecular Weight), End User (Hospital, Orthopedic Clinics, Ambulatory Care Centers, And Others), Distribution Channel (Direct Tender And Retail Sales) https://www.databridgemarketresearch.com/reports/north-america-viscosupplementation-market

Europe Viscosupplementation Market, By Source (Animal Origin And Non-Animal Origin), Age Group (Geriatric And Adults), Injection (Single Injection, Three Injections, And Five Injections), Molecular Weight (Intermediate Molecular Weight, Low Molecular Weight And High Molecular Weight), End User (Hospital, Orthopedic Clinics, Ambulatory Care Centers, And Others), Distribution Channel (Direct Tender And Retail Sales) https://www.databridgemarketresearch.com/reports/europe-viscosupplementation-market

Middle East & Africa Viscosupplementation Market, By Source (Animal Origin And Non-Animal Origin), Age Group (Geriatric And Adults), Injection (Single Injection, Three Injections, And Five Injections), Molecular Weight (Intermediate Molecular Weight, Low Molecular Weight And High Molecular Weight), End User (Hospital, Orthopedic Clinics, Ambulatory Care Centers, And Others), Distribution Channel (Direct Tender And Retail Sales) https://www.databridgemarketresearch.com/reports/middle-east-and-africa-viscosupplementation-market

Ophthalmic Viscosurgical Devices Market, By Type (Dispersive, Cohesive, Combined), Source (Animal, Biological, Semi-Synthetic), Application (Cataract Surgery, Vitreoretinal Surgery, Refractive Surgery, Keratoplasty), End Use (Hospitals, Diagnostic Centers, Eye Specialty Clinics, Others) https://www.databridgemarketresearch.com/reports/global-ophthalmic-viscosurgical-devices-market

Ophthalmic Viscoelastic Devices (Ovd) Market, By Product Type (Dispersive Ophthalmic Viscoelastic Devices, Cohesive Ophthalmic Viscoelastic Devices), Application (Cataract Surgery, Glaucoma Surgery, Vitreoretinal Surgery, Corneal Transplantation Surgery, Others), Composition (Sodium Hyaluronate, Chondroitin Sulfate, Hydroxypropyl Methylcellulose), End-User (Ophthalmic Clinics, Hospitals, and Academic and Research Institutes) Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) https://www.databridgemarketresearch.com/reports/global-ophthalmic-viscoelastic-devices-ovd-market

Veterinary Medicine Market, By Product (Biologics, Pharmaceuticals, Medicated Feed Additives), Animal Type (Production, Companion), Route of Administration (Oral, Parenteral, Others), End-User (Reference Laboratories, Point-of-Care Testing/In-House Testing, Veterinary Hospitals and Clinics, Others) https://www.databridgemarketresearch.com/reports/global-veterinary-medicine-market

Healthcare and Medical System Integrators Market, By Type (Horizontal Integration, Vertical Integration), Application (Government Hospitals, Private Hospitals and Clinics, Healthcare Organizations, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) https://www.databridgemarketresearch.com/reports/global-healthcare-and-medical-system-integrators-market

Hematology Oncology Market, By Hematology Product (Hematology Analyzers, Hematology Reagents, Flow Cytometers, Hematology Cell Counters, Slide Strainers, Coagulation Analyzers, Hematology Testing, Centrifuges, Hemoglobin meters, Others), Oncology Drug Class Type (Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy), Oncology Indication (Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Esophagus Cancer, Cervical Cancer, Kidney Cancer, Bladder Cancer, Others), Applications (Infectious Diseases, Cancer, Cardiovascular Disorders, Blood Screening, Diabetes, HIV, Auto – Immune Diseases), End Users (Hospitals, Clinical Testing Institutes, Patient Self- Testing, Other End- Users) https://www.databridgemarketresearch.com/reports/global-hematology-oncology-market

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:-

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com

Logo: https://mma.prnewswire.com/media/1011053/Data_Bridge_Market_Research_Logo.jpg